#2475 on the rich list of 14,452 insiders
Henry O. Gosebruch
EVP, Chief Strategy Officer at AbbVie; Director at ANI Pharmaceuticals; President & CEO at Neumora Therapeutics. Based in Princeton, New Jersey.
$51.9M
in disclosed stock, −$474K (−0.90%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 2475th of 14,452
- Companies held
- 3
- Largest holding
- ABBV, 98.7% of total
- Latest SEC filing
- Aug 19, 2026
What the $51.9M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| AbbVie ABBV Common Stock, $0.01 par value | In trust | 78,500 | $283.54 | $22.3M | 42.9% | Form 4, Feb 17, 2022 |
| AbbVie ABBV Common Stock, $0.01 par value | In trust | 53,500 | $283.54 | $15.2M | 29.2% | Form 4/A, May 16, 2022 |
| AbbVie ABBV Common Stock, $0.01 par value | Directly | 41,623 | $283.54 | $11.8M | 22.7% | Form 4/A, May 16, 2022 |
| AbbVie ABBV Common Stock, $0.01 par value | Profit sharing trust | 3,638 | $283.54 | $1.0M | 2.0% | Form 4/A, May 16, 2022 |
| AbbVie ABBV Common Stock, $0.01 par value | Indirectly (see filing footnote) | 3,457 | $283.54 | $980K | 1.9% | Form 4/A, Mar 1, 2022 |
| ANI Pharmaceuticals ANIP Common Stock | Directly | 6,662 | $69.13 | $461K | 0.9% | Form 4, Aug 19, 2026 |
| Neumora Therapeutics NMRA Common Stock | Directly | 462,345 | $0.35 | $160K | 0.3% | Form 4, Feb 14, 2024 |
| Neumora Therapeutics NMRA Common Stock | Through Lu Leng Felicia Chua Descendants 2012 Irrevocable Trust | 127,448 | $0.35 | $44K | 0.1% | Form 4, Feb 14, 2024 |
| Neumora Therapeutics NMRA Common Stock | Indirectly (see filing footnote) | 15,000 | $0.35 | $5K | 0.0% | Form 4, Feb 14, 2024 |
Share counts are the amounts Henry O. Gosebruch reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 2472 | Bill W. Wheat EVP and CFO, D.R. Horton. Arlington, TX | $51.9M |
| 2473 | Dunson K. Cheng Executive Chairman, Cathay General Bancorp. Los Angeles, CA | $51.9M |
| 2474 | Frederick R. Wilson Director, Etsy. New York, NY | $51.9M |
| 2475 | Henry O. Gosebruch EVP, Chief Strategy Officer, AbbVie. Princeton, NJ | $51.9M |
| 2476 | Ellen R. Alemany Director, First Citizens BancShares. Raleigh, NC | $51.9M |
| 2477 | Mark Samuel Hoplamazian See Remarks, Hyatt Hotels. Chicago, IL | $51.9M |
| 2478 | Brian G. Robins Chief Financial Officer, Snowflake. Menlo Park, CA | $51.9M |
Other AbbVie insiders
All ABBV insiders- Richard A. Gonzalez$110MDirector. #1413 overall
- Laura J. Schumacher$70.3MVice Chairman. #1698 overall
- Azita Saleki$60.9MEVP, CHIEF OPERATIONS OFFICER. #2125 overall
- Robert A. Michael$50.7MCHAIRMAN OF THE BOARD AND CEO. #2517 overall
- Michael Severino$43.1MVice Chairman. #2348 overall
- Thomas C. Freyman$37.9MDirector. #3121 overall
Questions
How much stock does Henry O. Gosebruch own?
Henry O. Gosebruch holds $51,911,189 in listed stock based on SEC filings and current prices, mostly AbbVie (ABBV). That ranks 2475th on the Stock Rich List.
Is this Henry O. Gosebruch's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.